Search Results - "OCHIAI, A"

Discovery of superconductivity in quasicrystal by Kamiya, K., Takeuchi, T., Kabeya, N., Wada, N., Ishimasa, T., Ochiai, A., Deguchi, K., Imura, K., Sato, N. K.

“…Superconductivity is ubiquitous as evidenced by the observation in many crystals including carrier-doped oxides and diamond. Amorphous solids are no exception…”
Get full text

Assessment of a HER2 scoring system for gastric cancer: results from a validation study by Hofmann, M, Stoss, O, Shi, D, Büttner, R, Van De Vijver, M, Kim, W, Ochiai, A, Rüschoff, J, Henkel, T

“…Aims:  Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is implicated in the development of various solid tumour types. Validated…”
Get full text

Prevalence and risk factors of zygotic splitting after 937 848 single embryo transfer cycles by Ikemoto, Y, Kuroda, K, Ochiai, A, Yamashita, S, Ikuma, S, Nojiri, S, Itakura, A, Takeda, S

“…Abstract STUDY QUESTION What is the prevalence of multiple pregnancy with zygotic splitting after single embryo transfer (SET)? SUMMARY ANSWER The prevalence…”
Get full text

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer by Mitsunaga, S, Ikeda, M, Shimizu, S, Ohno, I, Furuse, J, Inagaki, M, Higashi, S, Kato, H, Terao, K, Ochiai, A

“…Background: With this study, we sought to characterise the impact of pro-inflammatory cytokines on the outcomes of gemcitabine monotherapy (GEM) in patients…”
Get full text

Frequent MED12 mutations in phyllodes tumours of the breast by Yoshida, M, Sekine, S, Ogawa, R, Yoshida, H, Maeshima, A, Kanai, Y, Kinoshita, T, Ochiai, A

“…Background: Phyllodes tumours are rare fibroepithelial tumours of the breast, that include benign, borderline, and malignant lesions. Although the molecular…”
Get full text

MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes by Fujii, S, Tokita, K, Wada, N, Ito, K, Yamauchi, C, Ito, Y, Ochiai, A

“…EZH2 overexpression occurs in various malignancies and is associated with a poor outcome. We have so far demonstrated that EZH2 downregulates the important…”
Get full text

Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation by Nakayama, M, Sakai, E, Echizen, K, Yamada, Y, Oshima, H, Han, T-S, Ohki, R, Fujii, S, Ochiai, A, Robine, S, Voon, D C, Tanaka, T, Taketo, M M, Oshima, M

“…Tumor suppressor TP53 is frequently mutated in colorectal cancer (CRC), and most mutations are missense type. Although gain-of-functions by mutant p53 have…”
Get full text

Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer by Kuboki, Y., Yamashita, S., Niwa, T., Ushijima, T., Nagatsuma, A., Kuwata, T., Yoshino, T., Doi, T., Ochiai, A., Ohtsu, A.

“…In advanced gastric cancer (AGC), most clinical trials are designed on the basis of protein expression or gene amplification of specific genes. Recently,…”
Get full text

The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells by ITO, T.-K, ISHII, G, CHIBA, H, OCHIAI, A

“…Vascular endothelial growth factor (VEGF) production by stromal fibroblasts plays an important role in tumor angiogenesis. However, VEGF is also expressed by…”
Get full text

Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer by Oue, N, Naito, Y, Hayashi, T, Takigahira, M, Kawano-Nagatsuma, A, Sentani, K, Sakamoto, N, Zarni Oo, H, Uraoka, N, Yanagihara, K, Ochiai, A, Sasaki, H, Yasui, W

“…We built an in-house oligonucleotide array on which 394 genes were selected based on our Serial Analysis of Gene Expression (SAGE) data and previously reported…”
Get full text

Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma by Konishi, M., Iwasaki, M., Ochiai, A., Hasebe, T., Ojima, H., Yanagisawa, A.

“…Background: Although ductal resection margin status in extrahepatic cholangiocarcinoma is evaluated by intraoperative histological examination of frozen…”
Get full text

PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer by Muro, K., Uetake, H., Tsuchihara, K., Shitara, K., Yamazaki, K., Ota, M., Oki, E., Sato, T., Naitoh, T., Komatsu, Y., Kato, T., Yamanaka, K., Mori, I., Soeda, J., Hihara, M., Yamanaka, T., Akagi, K., Ochiai, A., Yoshino, T.

Get full text

Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification by Noro, R., Honda, K., Tsuta, K., Ishii, G., Maeshima, A.M., Miura, N., Furuta, K., Shibata, T., Tsuda, H., Ochiai, A., Sakuma, T., Nishijima, N., Gemma, A., Asamura, H., Nagai, K., Yamada, T.

“…Even if detected at an early stage, a substantial number of lung cancers relapse after curative surgery. However, no method for distinguishing such tumors has…”
Get full text

The use of non-surgical glue to repair perineal first-degree lacerations in normal birth: A non-inferiority randomised trial by Ochiai, A.M., Araújo, N.M., Moraes, S.D.T.A., Caroci-Becker, A., Sparvoli, L.G., Teixeira, T.T., Carvalho, R.R.

“…Surgical glue has been indicated for uncomplicated operatory wounds; however, it has a considerable cost. Non-surgical glue, a commercially available and…”
Get full text

Unified understanding of the valence transition in the rare-earth monochalcogenides under pressure by Jarrige, I., Yamaoka, H., Rueff, J.-P., Lin, J.-F., Taguchi, M., Hiraoka, N., Ishii, H., Tsuei, K. D., Imura, K., Matsumura, T., Ochiai, A., Suzuki, H. S., Kotani, A.

Get full text

Olaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer by Liu, Y.-Z., Hodgson, D., Locker, G., Lai, Z., Balcerzak, D., Sharpe, A., Barrett, J.C., Orr, M., Gutjahr, T.S., Dougherty, B., Roudier, M.P., Shi, X., Miller, R., Kim, W.H., Zeng, X., Ochiai, A., Im, S.-A., Xu, R.-H., Boku, N., Bang, Y.-J.

Get full text

Pressure tuning of an ionic insulator into a heavy electron metal: an infrared study of YbS by Matsunami, M, Okamura, H, Ochiai, A, Nanba, T

“…Optical conductivity [sigma(omega)] of YbS has been measured under pressure up to 20 GPa. Below 8 GPa, sigma(omega) is low since YbS is an insulator with an…”
Get full text

KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab by Bando, H, Yoshino, T, Tsuchihara, K, Ogasawara, N, Fuse, N, Kojima, T, Tahara, M, Kojima, M, Kaneko, K, Doi, T, Ochiai, A, Esumi, H, Ohtsu, A

“…Background: We aimed to compare the sensitive and quality-controlled KRAS testing with direct sequencing and to assess the impact on decision making of…”
Get full text

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer by Kawamoto, Y, Tsuchihara, K, Yoshino, T, Ogasawara, N, Kojima, M, Takahashi, M, Ochiai, A, Bando, H, Fuse, N, Tahara, M, Doi, T, Esumi, H, Komatsu, Y, Ohtsu, A

“…Background: KRAS mutations are predictive markers for the efficacy of anti-EGFR antibody therapies in patients with metastatic colorectal cancer. Although the…”
Get full text

2405 Comprehensive biomarker analyses in esophageal squamous cell carcinoma by Hatogai, K, Fujii, S, Kojima, T, Daiko, H, Nomura, S, Doi, T, Ochiai, A, Yoshino, T

Get full text